Cite
HARVARD Citation
Fukata, S. et al. (2022). Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma. Anti-cancer drugs. 33 (5), pp. 459-466. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fukata, S. et al. (2022). Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma. Anti-cancer drugs. 33 (5), pp. 459-466. [Online].